Publications Update

Publications Update # 139

Detailed review of Avutometinib and Defactinib

Publications Update # 138

Beware the power of prediction, focus review of GLP-1 Agonists and role in endometrial cancer

Publications Update # 136

Stress Resets by Dr. Jenny Taitz, ASCO guidelines review - WBC Growth Factors, Pregnancy in Childbearing Surgeons, ROSELLA Trial revisited, ADC updates - IDeate-PanTumor01

Publications Update # 135

Hemostatic agents video and summary one-pager, serous tubal intra-epithelial carcinoma (STIC) - risk of peritoneal carcinomatosis and role of restaging. Role of lymphadenectomy in early ovarian cancer.

Publications Update # 134

Updates in the Management of Pulmonary Embolism and Venous thromboembolism

Publications Update # 133

TED talk by Mary Ann Sieghart on closing the "authority gap" for women. Management of Rashes in Gynecology Oncology video, safe de-escalation of adjuvant therapies for early-stage POLE-mutated endometrial cancer, and pre-operative MRI is sufficient for evaluating early cervical cancer

Publications Update # 131

Accuracy of sentinel node biopsy for large vulvar tumors, new European guidelines for opportunistic salpingectomy, and the high response rates of pembrolizumab plus lenvatinib for clear cell carcinoma, benefits of ultra-low-dose nivolumab, and the benefits of silence.

Publications Update # 130

The influence of anxiety, search updates in GYOEDU, knowledge graph, mini-cards for publications update, opportunistic salpingectomy cost-effectiveness, ASCO guidelines - neoadjuvant chemotherapy in ovarian cancer and the futility ofmagnesium replacement

Publications Update # 129

Very low-risk cervical cancer appropriate for MIS simple hysterectomy (video), LASH trial, Pembrolizumab + Lenvatinib in Clear Cell Recurrences, cost-effective ways for genetic testing in ovarian cancer, PARP (olaparib) dose reductions and GYOEDU reminders

Publications Update # 128

How to form and break habits, MMR deficiency, MLH1 promoter hypermethylation, and outcomes, low-grade serous ovarian cancer 3026 trial, and FOLR1 expression in low-grade serous ovarian cancer. Updated video of neuroendocrine tumors.